Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
citicoline
fibrinolytic agents
fibroblast growth factor
neuroprotective agents
research
review article
streptokinase
tissue plasminogen activator, intravenous
treatment of neurologic disorder
Showing articles 1300 to 1350 of 3671 << Previous Next >>

Leukoaraiosis and Intracerebral Hemorrhage After Thrombolysis in Acute Stroke
Neurol 68:1020-1024, Palumbo,V.,et al, 2007

Life Expectancy After Perimesencephalic Subarachnoid Hemorrhage
Stroke 38:1222-1224, Greebe,P. &Rinkel,G.J.E., 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Individual Dopaminergic Neurons Show Raised Iron Levels in Parkinson Disease
Neurol 68:1820-1825, Oakley,A.E.,et al, 2007

Predictors of Diagnosis in Huntington Disease
Neurol 68:1710-1717, Langbehn,D.R.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

A 46-Year-Old Woman With Severe Weakness Following Acute Respiratory Distress Syndrome
Neurol 68:1529-1535, Waclawik,A.J.,et al, 2007

Investigating Suspected Cerebral Venous Thrombosis
BMJ 334:794-795, Smit,R. &Hourihan,M.D., 2007

The Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin for the Prevention of Venous Thromboembolism After Acute Ischaemic Stroke (PREVAIL Study): An Open-Label Randomised Comparison
Lancet 369:1347-1355, Sherman,D.G.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
Stroke 38:1881-1885,1736, Hackam,D.D. &Spence,J.D., 2007

Short-Term Risk for Stroke Is Doubled in Persons With Newly Treated Type 2 Diabetes Compared With Persons Without Diabetes: A Population-Based Cohort Study
Stroke 38:1739-1743, Jeerakathil,T.,et al, 2007

Repetitive Strain Injury
Lancet 369:1815-1822, van Tulder,M.,et al, 2007

Back Surgery -- Who Needs It?
NEJM 356:2239-2245, Deyo,R.A., 2007

Recurrence of Afebrile Status Epilepticus in a Population-Based Study in Rochester, Minnesota
Neurol 69:73-78, Hesdorffer,D.C.,et al, 2007

Prednisolone Does Not Reduce Withdrawal Headache
Neurol 69:26-31, Boe,M.G., et al, 2007

Epidemic Meningitis, Meningococcaemia, and Neisseria meningitidis
Lancet 369:2196-2210, Stephens,D.S.,et al, 2007

Amyotrophic Lateral Sclerosis
Lancet 369:2031-2041, Mitchell,J.D. & Borasio,G.D., 2007

Prothombotic Mutations as Risk Factors for Cryptogenic Ischemic Cerebrovascular Events in Young Subjects With Patent Foramen Ovale
Stroke 38:2070-2073, Botto,N.,et al, 2007

The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Stroke 38:2196-2203, Arenillas,J.F.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Arteriovenous Malformations of the Brain
NEJM 356:2704-2712, Friedlander,R.M., 2007

Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole
Arch Neurol 64:820-824, Kleiner-Fisman,G. &Fisman,D.N., 2007

Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007

Efficacy of Folic Acid Supplementation in Stroke Prevention: A Meta-Analysis
Lancet 369:1876-1882,1841, Wang,X.,et al, 2007

Causative Factors and Epidemiology of Bilateral Vestibulopathy in 255 Patients
Ann Neurol 61:524-532, Zingler,V.C.,et al, 2007

Paroxysmal Extreme Pain Disorder (Previously Familial Rectal Pain Syndrome)
Neurol 69:586-595, Fertleman,C.R.,et al, 2007

Independent Predictors of Stroke in Patients with Atrial Fibrillation
Neurol 69:546-554, The Stroke Risk in Atrial Fibrillation Working Group, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Precipitating Factors of Spontaneous Spinal CSF Leaks and Intracranial Hypotension
Neurol 69:700-702, Schievink,W.I. &Luoy,C., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

A Genetic Risk Factor for Periodic Limb Movements in Sleep
NEJM 357:639-647, Stefansson,H.,et al, 2007

Warfarin Versus Aspirin for Stroke Prevention in an Elderly Community Population With Atrial Fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A Randomised Controlled Trial
Lancet 370:493-503,460, Mant,J.,et al, 2007

Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients
Storke 38:2738-2744, Fiehler,J.,et al, 2007

Risk Factors for Intracerebral Hemorrhage in a Pooled Prospective Study
Stroke 38:2718-2725, Sturgeon,J.D.,et al, 2007

An Unexpected Cause of Fever and Seizures
Lancet 370:908, Kochar,D.K.,et al, 2007

Surgical Versus Nonsurgical Treatment for Back Pain
NEJM 357:1255, Copeland,B., 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Increased Risk of Cognitive Impairment or Dementia in Women who Underwent Oophorectomy Before Menopause
Neurol 69:1074-1083, Rocca,W.A.,et al, 2007

Relation Between Smoking and Risk of Dementia and Alzheimer Disease: The Rotterdam Study
Neurol 69:998-1005, Reitz,C.,et al, 2007

Mobile Aortic Plaques Are a Cause of Multiple Brain Infarcts Seen on Diffusion-Weighted Imaging
Stroke 38:2470-2476, Ueno,Y.,et al, 2007

Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Stroke 38:2459-2463,2409, Baruch,L.,et al, 2007

Hypoplastic Vertebral Artery: Frequency and Associations With Ischaemic Stroke Territory
JNNP 78:954-958, Park-J.-H.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Seizure Occurrence: Precipitants and Prediction
Neurol 69:1905-1910, Haut,S.R.,et al, 2007

Obstructive Sleep Apnea is Associated With Seizure Occurrence in Older Adults With Epilepsy
Neurol 69:1823-1827, Chihorek,A.M.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Congenital Lymphocytic Choriomeningitis Virus Infection: Spectrum of Disease
Ann Neurol 62:347-355, Bonthius,D.J.,et al, 2007

Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trial
Stroke 38:2965-2971, Ford,G.A.,et al, 2007



Showing articles 1300 to 1350 of 3671 << Previous Next >>